Transgene Biotek informs about trading window closure

08 Apr 2020 Evaluate

Transgene Biotek has informed that in terms of Company's Code of Internal Procedure and Conduct for Regulating, Monitoring and Reporting of trading by Designated persons, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, read with the clarification issued by BSE vide Circular No. LIST/COMP/01/2019-20 dated 02nd April 2019, the Trading window for dealing in the securities of the Company for all Designated Persons and immediate relatives of Designated Person, will remain closed from immediate effect till expiry of 48 hours after the financial results for the quarter and year ended 31 st March 2020 become generally available information. The date of meeting of the Board of Directors to approve the Audited financials results of the Company for the quarter and year ended March 31, 2020 will be informed in due course.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

3.86 0.07 (1.85%)
17-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7073.00
Max Healthcare Inst 1084.80
Narayana Hrudayalay 1854.95
Aster DM Healthcare 499.60
Global Health 1267.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...